Heron Therapeutics Inc (NASDAQ:HRTX)
| 1.34 Delayed Data As of Dec 01 |  +0.11 / +8.94%Today’s Change | 0.50 Today|||52-Week Range 3.41 | -46.40% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $199.6M |
Company Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Contact Information
Heron Therapeutics, Inc. 4242 Campus Point Court San Diego California 92121 |
Employees
Shareholders
| Other institutional | 58.98% |
| Individual stakeholders | 30.04% |
| Mutual fund holders | 25.00% |
Top Executives
| Craig A. Collard | Chief Executive Officer & Director |
| Ira Duarte | Chief Financial Officer |
| Thomas B. Ottoboni | Chief Scientific Officer & SVP-Pharmaceutical |
| Chris M. Storgard | Chief Medical Officer |
| William P. Forbes | Chief Development Officer & Executive VP |
